Regenerative Medicine

Regenerative Medicine英文简介

Regenerative medicine replaces or regenerates human cells, tissue or organs, to restore or establish normal function*. Since 2006, Regenerative Medicine has been at the forefront of publishing the very best papers and reviews covering the entire regenerative medicine sector. The journal focusses on the entire spectrum of approaches to regenerative medicine, including small molecule drugs, biologics, biomaterials and tissue engineering, and cell and gene therapies – it’s all about regeneration and not a specific platform technology. The journal’s scope encompasses all aspects of the sector ranging from discovery research, through to clinical development, through to commercialization. Regenerative Medicine uniquely supports this important area of biomedical science and healthcare by providing a peer-reviewed journal totally committed to publishing the very best regenerative medicine research, clinical translation and commercialization.

Regenerative Medicine provides a specialist forum to address the important challenges and advances in regenerative medicine, delivering this essential information in concise, clear and attractive article formats – vital to a rapidly growing, multidisciplinary and increasingly time-constrained community.

Despite substantial developments in our knowledge and understanding of regeneration, the field is still in its infancy. However, progress is accelerating. The next few decades will see the discovery and development of transformative therapies for patients, and in some cases, even cures. Regenerative Medicine will continue to provide a critical overview of these advances as they progress, undergo clinical trials, and eventually become mainstream medicine.

Regenerative Medicine中文简介

《Regenerative Medicine》是一本由FUTURE MEDICINE LTD出版商出版的专业医学期刊，该刊创刊于2006年，刊期Bimonthly，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：工程技术 4区，小类学科：细胞与组织工程 4区；工程：生物医学 4区；在JCR（Journal Citation Reports）分区等级为Q3。该刊发文范围涵盖细胞与组织工程等领域，旨在及时、准确、全面地报道国内外细胞与组织工程工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为3.21，平均审稿速度较慢,6-12周。

中科院分区最新升级版（当前数据版本：2021年12月最新升级版）

大类学科	分区	小类学科	分区	Top期刊	综述期刊
工程技术	4区	CELL & TISSUE ENGINEERING 细胞与组织工程 ENGINEERING, BIOMEDICAL 工程：生物医学	4区 4区	否	否

JCR分区（当前数据版本：2021-2022年最新版）

JCR分区等级	JCR所属学科	分区	影响因子
Q3	ENGINEERING, BIOMEDICAL	Q3	3.21
	CELL & TISSUE ENGINEERING	Q4

期刊指数

影响因子	h-index	Gold OA文章占比	研究类文章占比	OA开放访问	平均审稿速度
3.21	53	21.03%	56.34%	未开放	较慢,6-12周

IF值(影响因子)趋势图